Candidate Biomarkers Associated With Circulating Tumor Cell Status in Metastatic Colorectal Cancer

Area of Science:

• Oncology
• Molecular Biology
• Biomarker Discovery

Background:

• Colorectal cancer (CRC) is a leading global cancer.
• Circulating tumor cells (CTCs) are crucial in cancer metastasis.
• MicroRNAs (miRNAs) show promise as biomarkers for CTC detection.

Purpose of the Study:

• To investigate circulating miRNA signatures associated with CTC status in metastatic colorectal cancer (mCRC).
• To identify potential miRNA biomarkers for predicting CTC presence in mCRC patients.

Main Methods:

• Assessed CTC status in mCRC patients using AdnaTest ColonCancer technology.
• Analyzed miRNA profiles via Agilent miRNA microarray in CTC-positive, CTC-negative, and healthy individuals.
• Validated candidate miRNAs using quantitative polymerase chain reaction (qPCR) and in silico analysis.

Main Results:

• Identified dysregulated miRNA signatures linked to CTC status in mCRC.
• Discovered three downregulated miRNAs (hsa-miR-199a-5p, hsa-miR-326, hsa-miR-500b-5p) in CTC-positive versus CTC-negative mCRC patients.
• Confirmed these miRNAs as potential predictors of CTC status via qPCR.

Conclusions:

• Proposed novel miRNA biomarker candidates for predicting CTC status in mCRC.
• Highlighted potential for miRNA-based detection of CTCs in mCRC management.
• Suggested implications for translational medicine in mCRC treatment.